top of page

Science

We are deeply engaged in investments in new scientific developments in the areas of biotech, healthcare, technology, fintech, and disruptive technologies across all sectors. We pursue these efforts through direct and co-investments with other family offices and institutional investors. Our investments include start-ups, later-stage private companies, and public companies directly and through hedge, private equity, and venture funds. 

Sepehr Manochehry, PhD

Sepehr Manochehry joined the Cooper Family Office as a healthcare investment analyst after working with several investment banks in progressively senior roles in equity research, most recently at Eight Capital as a Principal Analyst. He received his PhD in Biochemistry & Biomedical Sciences from McMaster University as well as a Bachelor of Science in Psychology from Wilfrid Laurier University. 

Dr. Manochehry has a combination of research experience as a bench-top scientist as well as in the capital markets working with healthcare companies as an equity research analyst. He is active in portfolio investments in healthcare, where he focuses on evaluating early-stage companies on behalf of the family office in addition to advising with the hedge fund and private equity teams in biotechnology.

Sofia Sakopoulos, MA

Sofia Sakopoulos joined the Cooper Family Office as a healthcare and biotechnology investment analyst. She received her Bachelor of Science in Behavioral Neuroscience from Northeastern University and received her Master of Arts in Psychology with a concentration in Mental Health and Substance Abuse Counseling at The New School for Social Research. Ms. Sakopoulos has had extensive molecular neuroscience research experience with the Stanley Center for Psychiatric Research at the Broad Institute of MIT & Harvard. She conducts psychological research focused on brain health and the integration of cutting-edge pharmacological science and psychological interventions for an effective understanding of treatment interventions for brain circuitry and neural mechanisms associated with advanced psychopathologies.

 

Ms. Sakopoulos is active in portfolio investments in healthcare, biotechnology, hedge funds, private equity, and venture. Her personal interests include traveling, sports, the arts, and philanthropy, in which she volunteers her time to coach tennis to children living in the projects in Brooklyn, New York.

Sepehr Manochehry, PhD

Sepehr Manochehry joined the Cooper Family Office as a healthcare investment analyst after working with several investment banks in progressively senior roles in equity research, most recently at Eight Capital as a Principal Analyst. He received his PhD in Biochemistry & Biomedical Sciences from McMaster University as well as a Bachelor of Science in Psychology from Wilfrid Laurier University. 

Dr. Manochehry has a combination of research experience as a bench-top scientist as well as in the capital markets working with healthcare companies as an equity research analyst. He is active in portfolio investments in healthcare, where he focuses on evaluating early-stage companies on behalf of the family office in addition to advising with the hedge fund and private equity teams in biotechnology.

bottom of page